There has been a transformative merger between Paragon Care Group and Clifford Hallam Healthcare (CH2) to create ParagonCare - a leading healthcare wholesaler, distributor, and manufacturer operating across growing healthcare markets in the Asia Pacific region.

The combined entity has an expanded reach including Hospital Pharmacy, Community Pharmacy, Primary Care, Aged Care and Community as well as a Contract Logistics servicing the healthcare industry.

Our extended customer base has access to a broader range of products and services with the most cost-effective solutions.

Explore more: 

Learn more about ParagonCare | CH2 here: www.ch2.net.au
Place orders directly online via ParagonCare Direct: direct.paragoncare.com.au 

On World Optometry Day 2025, Channel 9’s Today Show featured a special segment with 1001 Optical, showcasing the groundbreaking NIDEK DUO2 OCT in collaboration with ParagonCare | Designs For Vision. This advanced imaging system is revolutionising optometry by providing precise, high-quality images essential for diagnosing and monitoring eye health.

The NIDEK DUO2 OCT, a state-of-the-art imaging system, is designed to provide optometrists with rapid, high-quality retinal and optic nerve imaging, helping to detect and monitor eye conditions with greater confidence. With deep-learning-powered B-scan denoising and RetinaMap technology, it delivers enhanced clarity and diagnostic efficiency while minimising patient movement artifacts. The system also features a built-in 12-megapixel fundus camera, enabling detailed imaging for improved clinical decision-making.

“Early and accurate detection of retinal and optic nerve conditions is essential in modern optometry,” said Marnie Bateman, General Manager of Non-Acute Sales at ParagonCare | DFV. “The NIDEK DUO2 OCT is an important tool that helps optometrists provide high-quality patient care through advanced imaging capabilities. We are thrilled to see this technology showcased on a national platform.”

As a trusted distributor of NIDEK technology in Australia, ParagonCare | DFV is committed to equipping optometry and ophthalmology professionals with state-of-the-art solutions that streamline clinical workflows and improve patient care outcomes. Don’t miss this exciting segment on Channel 9’s Today Show as we explore how cutting-edge technology is shaping the future of optometry.

Watch now.

For more information on the NIDEK DUO2 OCT, reach out to the team.

MT WAVERLEY, VIC – March 12, 2025

ParagonCare the exclusive distribution partner of BV, is excited to announce that Body Vision Medical’s LungVision^® AI-driven advanced imaging system has received regulatory approval from the Therapeutic Goods Administration (TGA) in Australia.

Body Vision Medical’s innovative technology ensures that hospitals and clinics throughout Australia will now have access to state-of-the-art AI-driven imaging solutions, reinforcing the shared commitment to advancing lung cancer diagnosis and treatment.

"We are excited to welcome Body Vision Medical’s technology to our portfolio, as it strengthens our commitment to advancing augmented lung and respiratory medicine through cutting-edge AI. Body Vision's real-time imaging technology offers remarkable opportunities, significantly enhancing the chances for earlier cancer detection and ultimately improves lung cancer survival rates." – Tiffany Chiew, General Manager, Capital and Service.

Lung cancer remains the leading cause of cancer-related deaths in Australia, with an estimated 14,500 new cases diagnosed annually. With the Australian Government Department of Health and Aged Care launching the National Lung Cancer Screening Program (NLCSP) to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules (SPNs).

LungVision^®, an AI-driven imaging system that transforms any C-arm into a 3D imaging system, empowers physicians with real-time navigation and enhanced visualisation to achieve more precise and accurate bronchoscopic biopsies. By enabling more confident diagnoses, LungVision^® supports the clinical goals of the NLCSP and can enhance patient outcomes. ParagonCare is proud to partner with Body Vision Medical to support this national initiative by providing solutions that align with evolving screening guidelines and clinical practices.

“This approval represents a major step forward in our global mission to transform lung cancer care,” said Matt Baker, CEO at Body Vision Medical. “We are thrilled to partner with ParagonCare to make LungVision^® available in Australia and New Zealand, where the need for accurate, early-stage lung cancer diagnosis has never been more urgent.”

ParagonCare will be launching LungVision^® to the Australian market at the TSANZSRS the combined meeting for the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, held from 21^st -25^th March in Adelaide, South Australia.

We invite you to visit the ParagonCare booth (#54) to meet our team, experience a live demo, and discuss how LungVision^® can contribute to the success of the NLCSP and your lung cancer screening efforts.

For more information about LungVision^® and its availability in Australia and New Zealand, please contact the ParagonCare team via the ParagonCare website or below contacts.

Visit bodyvisionmedical.com to learn more and connect with us on LinkedIn.

ParagonCare Media Contact: 
Kylie Inserra 
Group Communications & Branding Lead 
T 1300 726 226 
E kylie.inserra@paragoncare.com.au 
W paragoncare.com.au

ParagonCare Customer Contact: 
Tiffany Chiew 
General Manager Capital & Service 
T 1800 228 118 
E tiffany.chiew@paragoncare.com.au 
W paragoncare.com.au

MOUNT WAVERLEY VIC - 19 February 2025

In a groundbreaking development for Australian healthcare, ParagonCare has unveiled its strategic partnership with Coreline Soft, an AI-driven, innovative lung cancer screening
software designed to enhance early detection and diagnosis.

Coreline Soft’s comprehensive imaging analysis solutions integrate seamlessly into clinical practice and are transforming diagnosis workflows. Their AI-powered medical imaging solutions are revolutionising how hospitals detect and manage multiple conditions from a single CT scan. This creates opportunities for earlier intervention and potentially better
patient outcomes.

Coreline Soft’s AVIEW product line offers 3D CT image analysis solutions. AVIEW LCS Plus, which can simultaneously screen for the "BIG 3" in lung cancer screening (lung cancer, emphysema, and coronary artery calcification), supports large-scale data analysis and precise nodule detection. It reduces diagnostic variability among medical professionals and is currently supplied to lung cancer screening programs in South Korea, Europe, Germany, Italy, and more.

“By integrating AI-powered healthcare solutions into our portfolio, ParagonCare is reinforcing its commitment to advancing patient care and streamlining radiology workflows. Our partnership with Coreline Soft is a significant step forward in harnessing innovative technology to support healthcare professionals and improve patient outcomes.” – Tiffany Chiew, General Manager, Capital and Service.

"Partnering with ParagonCare is a significant step in expanding access to our AI lung cancer screening solutions across Australia," said Jason Suh, Director of Overseas Business Department at Coreline Soft. "With their deep expertise in medical imaging and strong local presence, ParagonCare is an ideal partner to bring advanced screening technology to more healthcare providers. Together, we aim to enhance early detection, improve diagnostic accuracy, and support better patient outcomes—starting with the NLCSP in July."

ParagonCare is excited to launch the Coreline Soft to the Australian market at the Australian Lung Cancer Conference (ALCC) 2025, held in Adelaide from 19th to 21st February, South Australia.

This year, with the commencement of the National Lung Cancer Screening Program (NLCSP) in Australia, the conference emphasizes the transformative potential of early detection in reducing lung cancer mortality. ParagonCare is proud to partner with Coreline Soft to support this national initiative by providing solutions that align with evolving screening
guidelines and clinical practices.

We invite you to visit the Coreline booth (#3) to meet our team, experience a live demo, and discuss how Coreline Soft can contribute to the success of the NLCSP and your lung cancer screening efforts.

Please contact the ParagonCare team for more information about the innovative Coreline Soft via the website or below contacts.

About ParagonCare
A leader in healthcare technology, devices, software, and consumables, ParagonCare Limited (ASX: PGC) is dedicated to meeting the dynamic needs of the healthcare industry. By harnessing expertise, agility, and strong partnerships, ParagonCare is at the forefront of delivering innovative solutions that improve patient experiences and optimise healthcare workflows.

About Coreline Soft
Coreline Soft is a global leader in AI-powered medical imaging solutions, specialising in advanced CT image analysis for lung cancer screening and comprehensive chest CT interpretation. Driven by innovation and precision, Coreline’s AI technology enhances early disease detection, ensures diagnostic consistency, and optimises radiology workflows. Trusted by national screening programs and leading medical institutions worldwide, Coreline Soft is committed to advancing patient care through cutting-edge imaging technology.

ParagonCare Media Contact:
Kylie Inserra
Group Communications & Branding Lead
T 1300 726 226
E kylie.inserra@paragoncare.com.au
W paragoncare.com.au

ParagonCare Customer Contact:
Tiffany Chiew
General Manager Capital & Service
T 1800 228 118
E tiffany.chiew@paragoncare.com.au
W paragoncare.com.au

Clifford Hallam Healthcare Pty Ltd (ACN 001 655 554) Terms & Conditions of Sale

In accordance with the requirements of the Workplace Gender Equality Act 2012 (Act), please be advised that on 24 May 2024, Paragon Care lodged its annual public report with the Workplace Gender Equality Agency (Agency).

This data is reported in the following documents:

• Questionnaire – public report
• Workforce Management Statistics – public report
• Workplace Profile – public report

Please refer any questions regarding the content or the finding of this report to hr@paragoncare.com.au

Infusion pumps are a staple of modern medicine. They're used for everything from simple IVs to complex chemotherapies.

Why are infusion pumps so popular? What makes them so useful and reliable?

This blog will talk about what infusion pumps are and how they've changed how healthcare is delivered worldwide. We'll also discuss some of their benefits, as well as their types.

What are Infusion Pumps?

An infusion pump is an automated medical device that delivers medication or fluids to patients through a catheter or IV. These pumps are usually programmed to administer a specific dose of medication at regular intervals and can be programmed to release the medication at different rates over time.

In most cases, an infusion pump requires a skilled person to operate, using the device's in-built software interface to set the delivery rate and time. The capacity to provide extremely tiny quantities of fluids and to distribute fluids at precisely programmed rates or automatic intervals are two of the main benefits of infusion pumps compared to traditional methods of fluid administration. Insulin, other hormones, antibiotics, chemotherapeutic treatments, and pain relievers are only some of the nutrients and pharmaceuticals that can be transported through these methods.

Types of Infusion Pumps

There are several types of infusion pumps:

Stationary Infusion Pumps

Stationary infusion pumps are typically found in hospitals or other healthcare facilities. They are usually connected to an IV bag with tubing, which provides the medication or fluid needed for the patient to receive treatment. Healthcare professionals can program these pumps to deliver certain amounts of nutrition, antibiotics, and pain medication at specific times throughout the day or night.

Ambulatory Infusion Pumps

Ambulatory infusion pumps are portable devices that allow patients with chronic conditions such as diabetes or congestive heart failure to self-administer their medications while in public or travelling away from home. They're also known as wearable infusion pumps because they're small enough for patients to wear on their bodies, like a vest or belt pack.

Syringe Pumps

Such infusion pumps are ideal for administering modest doses of medications. They are commonly used on infants and toddlers. A small amount of medication, such as hormones, can be administered with precision using an infusion pump. A motor with a plunger-like pumping device powers the infusion pump.

Large-volume pumps (LVPs)

The LVPs are infusion pumps that can provide vast amounts of fluids, such as food or medicine. Typically, electronic peristaltic pumps are used in LVPs. A roller controls the pump, which can be operated manually or through a computer.

Smart Infusion Pumps

Smart infusion pumps are controlled by a microprocessor which monitors the flow rate and volume of fluid being delivered to the patient at all times. They can be programmed to administer multiple doses at varying intervals throughout the day or night, depending on the drug's delivery type. These devices can also tell when an error has occurred, such as an air bubble entering the tubing or a malfunctioning sensor which prevents them from delivering any more fluid until these problems have been resolved. This means that if there is ever an issue with your drip set or IV bags, you will know about it immediately through an alarm so you can fix it before any serious damage is done.

Benefits of Infusion Pumps

Infusion pumps are popular because they can make life easier for patients, caregivers, and medical professionals. Here are some of the most common benefits:

• Better patient comfort
• Reduced risks of infection
• More efficient use of hospital resources
• Reduced costs
• Provide convenience to caregivers and health professionals
• Deliver accurate doses of medication on time

The Rise of the Global Infusion Pumps and Accessories Market

The global infusion pumps and accessories market is expected to reach USD 13264.18 Million by 2030. The main driver for this growth is the increased demand for patient safety solutions in hospitals and other healthcare facilities, which has increased infusion pump sales.

The rise in popularity of infusion pumps is being driven by several factors, including:

• Growing demand for medical equipment
• Expanding the use of disposable products
• Increasing government support for the healthcare industry

The rising prevalence of chronic diseases coupled with increasing hospitalisation rates is also the key factor driving the growth of this market. In addition, the growing adoption of IT infrastructure in hospitals for managing patient data is also expected to drive market growth over the forecast period.

Takeaway

It's no surprise that infusion pumps are so popular. They're a crucial part of healthcare and medical facilities worldwide and are an integral part of a healthcare facility’s medical and surgical supplies.

Infusion pumps are designed to deliver precise doses of medication or other substances through a catheter into a patient's body. In many cases, these pumps are controlled remotely by medical staff. The level of precision these devices offer can make all the difference in the outcome of a procedure.

That is why it is important to invest in high-quality infusion pumps for your medical facility that is built to last.

At Paragon Care, we offer a wide range of medical and surgical supplies so that no matter what your needs are, you'll find something that meets them perfectly.